EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Maternal gestational hypertension, smoking and pre‐eclampsia are associated with metabolic dysfunction‐associated fatty liver disease in overweight offspring

Hanna de Ruyter, Linnea Aitokari, Siiri Lahti, Hanna Riekki, Heini Huhtala, Timo Lakka, Hannele Laivuori iD, Kalle Kurppa iD

Acta Obstetricia et Gynecologica Scandinavica · 2024

DOI: 10.1111/aogs.14816 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, 2024. Verfasst von Hanna de Ruyter und 7 weiteren Autor:innen. Beteiligte Einrichtung: Tampere Center for Child, Adolescent and Maternal Health Research, Tampere University and Tampere University Hospital, Wellbeing Services County of P…. Hauptthemen laut MEDLINE: Pre-Eclampsia, Hypertension, Pregnancy-Induced, Overweight, Smoking. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Juho Vainion Säätiö, Maud Kuistilan Muistosäätiö, Emil Aaltosen Säätiö.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Due to a steep increase in obesity, metabolic dysfunction‐associated fatty liver disease (MAFLD) has also become the most common chronic hepatic condition among children and adolescents. Various maternal and pregnancy‐related factors have also been implicated in the development of MAFLD, but human studies remain scarce. Material and methods Comprehensive data of 460 overweight or obese children aged 2–16 years were collected and combined with data on selected maternal and pregnancy‐related factors for a case–control study. MALFD was defined as alanine aminotransferase >2× upper limit of normal. Children with and without MAFLD were compared regarding to the study variables and multivariable regression analysis was utilized.

Results

Median age of the study children was 11.8 (quartiles 9.1–14.2) years; 44% were girls and 17.8% had MAFLD. Children with MAFLD were older (12.7 vs. 11.6 years, p = 0.002), while the groups did not differ age‐standardized body mass index (BMI‐SDS) or gender. Factors associated with MAFLD in a multivariable model considering also the offspring's present BMI‐SDS, sex, and maternal prepregnancy overweight, were child's older age (odds ratio [OR] 1.16, 95% confidence interval [CI]: 1.06–1.28), maternal gestational smoking (OR 2.01, 95% CI: 1.16–3.47), gestational hypertension (OR 3.44, 95% CI: 1.08–11.0) and pre‐eclampsia (OR 2.93, 95% CI: 1.15–7.45). There was no significant association between MAFLD and maternal BMI, birth anthropometrics or perinatal complications.

Conclusions

Maternal smoking, gestational hypertension and pre‐eclampsia were associated with MAFLD among overweight or obese children. Further prospective studies are needed to verify causal relationships.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pre-EclampsiaHypertension, Pregnancy-InducedOverweightSmokingHumansFemalePregnancyChildAdolescentMaleCase-Control StudiesChild, PreschoolRisk FactorsPrenatal Exposure Delayed EffectsNon-alcoholic Fatty Liver DiseaseAdultBody Mass IndexPediatric ObesityFatty Liver

Stichwörter der Autor:innen

MAFLDchildrenfatty liverobesityoverweightpregnancyprenatal

Autor:innen und Institutionen

  • Tampere Center for Child, Adolescent and Maternal Health Research, Tampere University and Tampere University Hospital, Wellbeing Services County of Pirkanmaa, Tampere, Finland.
  • Celiac Disease Research Center, Tampere University, Tampere, Finland.
  • Faculty of Social Sciences, Tampere University, Tampere, Finland.
  • Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland.
  • Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital, Kuopio, Finland.
  • Kuopio Research Institute of Exercise Medicine, Kuopio, Finland.

ORCID-Profile: Hannele Laivuori, Kalle Kurppa

Förderung

  • Juho Vainion Säätiö
  • Maud Kuistilan Muistosäätiö
  • Emil Aaltosen Säätiö
  • Lastentautien Tutkimussäätiö
  • Orionin Tutkimussäätiö
  • the Paulo Foundation
  • Keliakialiitto
  • Valtion tutkimusrahoitus

Zitieren

APA

de Ruyter, H., Aitokari, L., Lahti, S., Riekki, H., Huhtala, H., Lakka, T., Laivuori, H., & Kurppa, K. (2024). Maternal gestational hypertension, smoking and pre‐eclampsia are associated with metabolic dysfunction‐associated fatty liver disease in overweight offspring. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.14816

Vancouver

de Ruyter H, Aitokari L, Lahti S, Riekki H, Huhtala H, Lakka T, et al. Maternal gestational hypertension, smoking and pre‐eclampsia are associated with metabolic dysfunction‐associated fatty liver disease in overweight offspring. Acta Obstetricia et Gynecologica Scandinavica. 2024. doi:10.1111/aogs.14816

BibTeX
@article{deRuyter2024,
  author = {de Ruyter, Hanna and Aitokari, Linnea and Lahti, Siiri and Riekki, Hanna and Huhtala, Heini and Lakka, Timo and Laivuori, Hannele and Kurppa, Kalle},
  title = {Maternal gestational hypertension, smoking and pre‐eclampsia are associated with metabolic dysfunction‐associated fatty liver disease in overweight offspring},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2024},
  doi = {10.1111/aogs.14816}
}
Kostenlos starten →